Navigation Links
Scientists Claim Developing A New Skin Test For The Early Detection Of Alzheimer’

Researchers at Blanchette Rockefeller Neurosciences Institute in Rockville have claimed that the discovery of enzymes, which react abnormally in the skin of patients// with Alzheimer's disease, could be developed as a quick, and painless test for the disease.

The researchers explained that not only would be quick and easy, but it would be the first accurate test for diagnosing Alzheimer's disease, which as of now could only be diagnosed by careful psychiatric assessments and by examining the brain after death. Researchers Tapan Khan and Daniel Alkon have said that their test could also distinguished Alzheimer's from other brain-damaging diseases such as Parkinson's and others.

The researchers while writing the Proceedings of the National Academy of Sciences, had said that it might even be used to find very early on the cause of Alzheimer’s, which is most common cause of dementia, at which stage drugs could act to the best of capabilities. Alkon also explained that the condition is usually very difficult to distinguish from other dementias or mild cognitive impairment.

He said, “Potential treatments of Alzheimer's, however, are likely to have their greatest efficacy before the devastating and widespread impairment of brain function that inevitably develops after four or more years.”

It has been explained that Alzheimer's disease is usually marked by inflammation that is caused by a variety of compounds in the body. More than 4.5 million people have Alzheimer's disease in the United States alone and 12 million worldwide and that there is no known cure. Alkon and Khan also found that the condition particularly stimulates a change in an enzyme called MAP Kinase Erik 1/2.

Testing this on various tissue samples taken from people who had died of known causes, including Alzheimer's, they found that when they tested the skin cells with bradykinin, which is a common inflammatory signal, the Erk 1/2 response obtained from patients with Alzheimer's was different from those seen in tissues from other people, including patients with dementia caused by Parkinson's disease, multiple infarct dementia and Huntington's chorea.

'"/>




Related medicine news :

1. Scientists plan human cloning clinic in the United States
2. Scientists found ancient Human Germ Killer
3. Scientists locate key hormone involved in appetite control
4. Scientists open the book of life
5. Scientists review SARS
6. Scientists crack dengue fever puzzle
7. Scientists push to lower hidden sodium in food
8. Indian Scientists Make Wide-Ranging Analysis And Annotation Of X Chromosome
9. Scientists have found effective brain regions for deep brain stimulation for Parkinson’s
10. Scientists reveal the secrets of sarcasm
11. Scientists Unveil Mechanism Behind Resistance to Severe Malaria
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... ... June 27, 2016 , ... ... the only authorized OSHA Training Institute Education Center headquartered in Northern California, has ... workers from extreme heat at their worksites. Employers with workers exposed to ...
(Date:6/27/2016)... California (PRWEB) , ... June 27, 2016 , ... "FCPX ... fully customizable inside of Final Cut Pro X," said Christina Austin - CEO of ... unique style. Final Cut Pro X users can now reveal the media ...
(Date:6/27/2016)... ... June 27, 2016 , ... TherapySites, ... its affiliation with Tennessee Counseling Association. This new relationship allows TherapySites ... Tennessee Counseling Association, adding exclusive benefits and promotional offers. , "TCA is extremely ...
(Date:6/27/2016)... (PRWEB) , ... June 27, ... ... in the patient payment industry today announced its strategic partnership with Connance, ... system workflows. , The two companies’ proven, proprietary technology combine to provide ...
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... ... cutting edge technology to revolutionize the emergency ambulance transport experience for the millions ... aware of how Uber has disrupted the taxi industry through the use of ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... One of Australia,s successful biotechnology ... a new biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ... to list on the ASX. Noxopharm is a clinic-ready ... a Phase 1 clinical study later this year. ... the biggest problems facing cancer patients - the ability of cancers ...
(Date:6/26/2016)... , June 27, 2016 Jazz Pharmaceuticals plc ... period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, ... of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ... (Eastern Daylight Time). As previously announced on ... a definitive merger agreement under which Jazz Pharmaceuticals has ...
(Date:6/26/2016)... June 27, 2016  VMS Rehab Systems, Inc. ( ... take whatever measures required to build a strong and ... is currently listed on the OTC Markets-pink current trading ... and CEO, "We are seeing an anomaly in market ... not only by the Company, but shareholders and market ...
Breaking Medicine Technology: